This article details an investigation of the function of renal artery progenitor cells in animal models of acute ischemic and hyperperfusion injuries. Renal artery-derived vascular progenitor cells (with surface markers consistent with endothelial progenitor cells) reduced albuminuria after hyperperfusion, and improved blood flow. These results show potential for therapeutic use of pro-angiogenic progenitor cells.